share_log

12 Health Care Stocks Moving In Monday's Pre-Market Session

Benzinga ·  Feb 12 21:05

Gainers

  • SeaStar Medical Holding (NASDAQ:ICU) shares rose 27.9% to $1.1 during Monday's pre-market session. The company's market cap stands at $71.6 million.
  • Aesthetic Medical Intl (NASDAQ:AIH) shares increased by 20.39% to $0.53. The company's market cap stands at $25.2 million.
  • Virios Therapeutics (NASDAQ:VIRI) stock rose 19.25% to $0.5. The company's market cap stands at $9.6 million.
  • Avinger (NASDAQ:AVGR) shares rose 18.1% to $3.3. The market value of their outstanding shares is at $4.2 million.
  • BioXcel Therapeutics (NASDAQ:BTAI) stock moved upwards by 15.68% to $2.44. The company's market cap stands at $74.1 million.
  • Exscientia (NASDAQ:EXAI) shares increased by 15.21% to $7.8. The market value of their outstanding shares is at $974.5 million.

Losers

  • AN2 Therapeutics (NASDAQ:ANTX) stock declined by 69.0% to $6.19 during Monday's pre-market session. The market value of their outstanding shares is at $184.0 million.
  • Larimar Therapeutics (NASDAQ:LRMR) shares fell 37.12% to $4.88. The market value of their outstanding shares is at $214.2 million.
  • Invivyd (NASDAQ:IVVD) shares declined by 13.06% to $4.33. The company's market cap stands at $476.8 million.
  • Intelligent Bio Solutions (NASDAQ:INBS) stock decreased by 11.9% to $5.96. The market value of their outstanding shares is at $4.3 million. The company's, Q2 earnings came out yesterday.
  • TC BioPharm (Holdings) (NASDAQ:TCBP) shares fell 11.85% to $1.34.
  • OKYO Pharma (NASDAQ:OKYO) shares fell 10.53% to $1.53. The market value of their outstanding shares is at $50.8 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment